Co-Authors
This is a "connection" page, showing publications co-authored by PAUL F MANSFIELD and CHARLES M BALCH.
Connection Strength
0.212
-
Cutaneous melanoma: current practice and surgical controversies. Curr Probl Surg. 1994 Apr; 31(4):253-374.
Score: 0.119
-
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma. Clin Cancer Res. 1998 Mar; 4(3):619-27.
Score: 0.039
-
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999 Mar; 17(3):976-83.
Score: 0.010
-
Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg. 1998 Sep; 176(3):239-43.
Score: 0.010
-
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998 Jun; 16(6):2253-60.
Score: 0.010
-
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol. 1997 Mar; 15(3):1039-51.
Score: 0.009
-
Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid). Cancer Biother. 1993; 8(4):307-18.
Score: 0.007
-
Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma. Int J Cancer. 1992 Aug 19; 52(1):52-9.
Score: 0.007